IL128531A0 - Method for treating heart failure - Google Patents

Method for treating heart failure

Info

Publication number
IL128531A0
IL128531A0 IL12853199A IL12853199A IL128531A0 IL 128531 A0 IL128531 A0 IL 128531A0 IL 12853199 A IL12853199 A IL 12853199A IL 12853199 A IL12853199 A IL 12853199A IL 128531 A0 IL128531 A0 IL 128531A0
Authority
IL
Israel
Prior art keywords
heart failure
treating heart
treating
failure
heart
Prior art date
Application number
IL12853199A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL128531A0 publication Critical patent/IL128531A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12853199A 1998-02-17 1999-02-15 Method for treating heart failure IL128531A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7493498P 1998-02-17 1998-02-17

Publications (1)

Publication Number Publication Date
IL128531A0 true IL128531A0 (en) 2000-01-31

Family

ID=22122537

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12853199A IL128531A0 (en) 1998-02-17 1999-02-15 Method for treating heart failure

Country Status (28)

Country Link
US (1) US6043260A (id)
EP (1) EP0951906A1 (id)
JP (1) JPH11292766A (id)
KR (1) KR19990072616A (id)
CN (1) CN1231176A (id)
AP (1) AP9901464A0 (id)
AR (1) AR017723A1 (id)
AU (1) AU1732999A (id)
BG (1) BG103180A (id)
BR (1) BR9900653A (id)
CA (1) CA2262252C (id)
EA (1) EA199900124A3 (id)
GT (1) GT199900015A (id)
HR (1) HRP990054A2 (id)
HU (1) HUP9900386A3 (id)
ID (1) ID23218A (id)
IL (1) IL128531A0 (id)
IS (1) IS4975A (id)
MA (1) MA26608A1 (id)
NO (1) NO990722L (id)
OA (1) OA10976A (id)
PA (1) PA8467401A1 (id)
PE (1) PE20000266A1 (id)
PL (1) PL331507A1 (id)
SG (1) SG81261A1 (id)
TN (1) TNSN99024A1 (id)
TR (1) TR199900328A2 (id)
ZA (1) ZA991220B (id)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US7125880B1 (en) 1995-06-06 2006-10-24 Pfizer Inc. Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
JP2003509478A (ja) * 1999-09-21 2003-03-11 エモリー・ユニバーシティ 血小板関連障害を処置する方法および組成物
CA2397633A1 (en) * 2000-01-18 2001-07-26 Pfizer Products Inc. Corticotropin releasing factor antagonists
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
US6992087B2 (en) 2001-11-21 2006-01-31 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
WO2003072107A1 (en) 2002-02-22 2003-09-04 Pharmacia & Upjohn Company Substituted pyrimidinones and pyrimidinthiones
AU2003220190A1 (en) * 2002-03-13 2003-09-29 Pharmacia & Upjohn Company Llc Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
BR0309551A (pt) * 2002-04-26 2005-02-09 Upjohn Co Derivados substituìdos de pirazina
EP1539736A1 (en) * 2002-09-12 2005-06-15 Pharmacia & Upjohn Company LLC Substituted 1,4-pyrazine derivatives
AR041470A1 (es) * 2002-10-17 2005-05-18 Upjohn Co Compuestos de pirrolo (1,2 - b) piridazina y sus usos
AU2003278542A1 (en) * 2002-11-21 2004-06-15 Pharmacia & Upjohn Company Llc Pyrazine compounds as crf modulators
MXPA05011387A (es) * 2003-04-23 2005-12-01 Pharmacia & Upjohn Co Llc Pirimidinonas y pirimidinotionas sustituidas.
JP2006525309A (ja) * 2003-05-07 2006-11-09 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ピロロ（１，２−ｂ）ピリダジン化合物、ならびにＣＲＦ−１受容体拮抗薬としてのその使用
EP1625115A1 (en) * 2003-05-09 2006-02-15 Pharmacia & Upjohn Company LLC Substituted pyrimidine derivatives
CA2525195A1 (en) * 2003-05-09 2004-11-18 Pharmacia & Upjohn Company Llc Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
MXPA05012082A (es) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Co Llc Compuestos como antagonistas del receptor crf1.
WO2005089639A2 (en) * 2004-03-16 2005-09-29 Talarico M D Matthew T Method for vascular dysregulation
US20060211710A1 (en) * 2005-03-17 2006-09-21 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US8338441B2 (en) * 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
BR9900653A (pt) 2000-10-17
OA10976A (en) 2001-11-05
AP9901464A0 (en) 1999-03-31
PL331507A1 (en) 1999-08-30
HUP9900386A3 (en) 1999-12-28
US6043260A (en) 2000-03-28
SG81261A1 (en) 2001-06-19
IS4975A (is) 1999-08-18
MA26608A1 (fr) 2004-12-20
NO990722D0 (no) 1999-02-16
AU1732999A (en) 1999-09-02
GT199900015A (es) 2000-07-26
CN1231176A (zh) 1999-10-13
CA2262252A1 (en) 1999-08-17
ZA991220B (en) 2000-08-16
EA199900124A2 (ru) 1999-08-26
TNSN99024A1 (fr) 2005-11-10
NO990722L (no) 1999-08-18
HUP9900386A2 (hu) 1999-11-29
HU9900386D0 (en) 1999-04-28
BG103180A (bg) 1999-09-30
PE20000266A1 (es) 2000-04-07
JPH11292766A (ja) 1999-10-26
ID23218A (id) 2000-03-30
AR017723A1 (es) 2001-09-12
EA199900124A3 (ru) 1999-12-29
CA2262252C (en) 2006-01-10
TR199900328A2 (xx) 1999-10-21
EP0951906A1 (en) 1999-10-27
KR19990072616A (ko) 1999-09-27
PA8467401A1 (es) 2000-09-29
HRP990054A2 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
SG81261A1 (en) Method for treating heart failure
SG50018A1 (en) Method for developing treatment
GB2359314B (en) Technique for treating wells
GB9605828D0 (en) Treatment method
HUP9902097A3 (en) Method for treating glaucoma
IL125762A0 (en) Method for treating heart failure
EP1009403A4 (en) METHOD FOR TREATING SCHIZOPHRENIA
PL341667A1 (en) Method of treating cooped
GB9714841D0 (en) Treatment method
AU4578501A (en) Method for treating congestive heart failure
IL126966A0 (en) Formulation and method for treating congestive heart failure
ZA975264B (en) Method for treating congestive heart failure.
ZA200007396B (en) Method of treatment.
HU9903735D0 (en) Method for treating congestive heart failure
GB9814785D0 (en) Waste treatment method
ZA988745B (en) Compounds for treating heart failure
EA199900063A3 (ru) Способ лечения организма пациента
GB9703102D0 (en) Treatment method
GB9822681D0 (en) Method of treatment
GB9614741D0 (en) Treatment method
GB9600610D0 (en) Treatment method
GB9614742D0 (en) Treatment method
GB9614743D0 (en) Treatment method
HU0500389D0 (en) Method for treating dyskinesias
HU9802108D0 (en) Funeral method